Quarterly report [Sections 13 or 15(d)]

Shareholders Equity (Details Narrative)

v3.25.1
Shareholders Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 27, 2023
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Sep. 30, 2024
Issued and outstanding common shares repurchased, percentage         5.40%  
Repurchased shares of common stock         2,717,000 6,129,000
Cost of shares repurchased, including commissions and fees         $ 1,575  
Restricted stock available to be granted under amended plan       4,005,000    
Stock options available to be granted under amended plan       3,161,000    
Restricted stock and stock options available to be granted under amended plan       7,166,000    
Restricted shares granted under AICP       48,000    
Board Of Directors Chairman [Member]            
Authorized amount for share repurchase program $ 20,000          
2013 Incentive Stock Plan [Member]            
Stock options available to be granted under amended plan       7,500,000    
Shares authorized to be granted under amended plan       15,000,000    
Restricted stock available to be granted under amended Plan       7,500,000    
Stock options granted       1,150,000    
Warrant [Member]            
Weighted average remaining contractual life       0 years   6 months
Weighted average exercise price per share       $ 2    
Warrants outstanding   77,000   77,000   77,000
Warrants [Member] | Stock Option [Member]            
Share-based compensation expense   $ 69 $ 79 $ 133 158  
Unrecognized compensation expense   621   $ 621    
Weighted average remaining vesting period       3 years 1 month 24 days    
Restricted Stock [Member]            
Share-based compensation expense   53 $ 78 $ 108 $ 152  
Unrecognized compensation expense   $ 197   $ 197    
Weighted average remaining vesting period       11 months 23 days